SB216763
CAS No. | 280744-09-4 | Cat. No. | BCP01764 |
Name | SB216763 | ||
Synonyms | SB-216763;SB 216763; | ||
Formula | C19H12Cl2N2O2 | M. Wt | 371.22 |
Description | SB 216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor (Ki = 9 nM for GSK-3α); competes with ATP. SB 216763 has minimal activity against 24 other protein kinases (IC50 > 10 μ M). Stimulates glycogen synthesis, gene transcription and is neuroprotective. SB 216763 also reduces pulmonary inflammation and fibrosis in a mouse model. | ||
Pathways | PI3K/Akt/mTOR Wnt/Stem Cell | ||
Targets | GSK3 |
Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.